Biogen has a total of 9624 patents globally, out of which 4119 have been granted. Of these 9624 patents, more than 38% patents are active. United States of America is where Biogen has filed the maximum number of patents, followed by Europe and Japan. Parallelly, USA seems to be the main focused R&D center and also is the origin country of Biogen.
Biogen was founded in 1978 by Phillip Allen Sharp, Charles Weissmann, Walter Gilbert and Kenneth Murray. Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis. As of June 2022, Biogen has a market cap of $29.38 Billion.
Read about some of the most popular patents of Biogen which have been covered by us in this article and also you can find Biogen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Biogen patent portfolio.
How many patents does the Founder and CEO of Biogen have?
The Founder Phillip Allen Sharp has 157, Charles Weissmann has 90, Walter Gilbert has 54 and Kenneth Murray has 105 patents and the CEO Michel Vounatsos have 0 patents.
How many patents does Biogen have?
Biogen has a total of 9624 patents globally. These patents belong to 1264 unique patent families. Out of 9624 patents, 3701 patents are active.
How Many Patents did Biogen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Biogen Applications Filed | Biogen Patents Granted |
| 2011 | 369 | 172 |
| 2012 | 392 | 217 |
| 2013 | 570 | 223 |
| 2014 | 386 | 219 |
| 2015 | 407 | 246 |
| 2016 | 252 | 225 |
| 2017 | 320 | 236 |
| 2018 | 272 | 243 |
| 2019 | 358 | 242 |
| 2020 | 246 | 212 |
| 2021 | 149 | 221 |
| 2022 | 16 | 57 |
How many Biogen patents are Alive/Dead?
Worldwide Patents
How Many Patents did Biogen File in Different Countries?
Countries in which Biogen Filed Patents
| Country | Patents |
| United States Of America | 1306 |
| Europe | 788 |
| Japan | 719 |
| Australia | 499 |
| Hong Kong (S.A.R.) | 491 |
| Canada | 374 |
| China | 371 |
| Korea (South) | 303 |
| Germany | 287 |
| Israel | 258 |
| New Zealand | 226 |
| Singapore | 213 |
| India | 206 |
| Spain | 202 |
| Denmark | 199 |
| Mexico | 181 |
| Brazil | 179 |
| Poland | 152 |
| Portugal | 132 |
| Slovenia | 119 |
| Eurasia | 113 |
| Austria | 106 |
| South Africa | 99 |
| Norway | 94 |
| Hungary | 89 |
| Taiwan | 77 |
| Serbia | 76 |
| Cyprus | 69 |
| Argentina | 69 |
| Malaysia | 67 |
| Indonesia | 62 |
| Philippines | 57 |
| Chile | 56 |
| Croatia | 56 |
| Iceland | 52 |
| Czech Republic | 48 |
| Lithuania | 47 |
| Albania | 46 |
| Slovakia | 45 |
| Estonia | 44 |
| United Kingdom | 39 |
| Georgia | 38 |
| Russia | 38 |
| Turkey | 38 |
| Ukraine | 35 |
| Bulgaria | 34 |
| Viet Nam | 19 |
| Uruguay | 18 |
| Montenegro | 16 |
| Colombia | 12 |
| Peru | 11 |
| Costa Rica | 10 |
| Yugoslavia/Serbia and Montenegro | 10 |
| Jordan | 10 |
| Romania | 9 |
| Finland | 9 |
| Luxembourg | 7 |
| Belarus | 5 |
| Former Yugoslav Republic of Macedonia | 5 |
| San Marino | 5 |
| Saudi Arabia | 5 |
| Ecuador | 4 |
| Africa | 4 |
| Netherlands | 4 |
| Brunei | 3 |
| Uzbekistan | 2 |
| Nicaragua | 2 |
| Tajikistan | 2 |
| Ireland | 1 |
| Italy | 1 |
| Tunisia | 1 |
| Honduras | 1 |
| Morocco | 1 |
| Gulf Cooperation Council | 1 |
| Greece | 1 |
| Dominican Republic | 1 |
| United Arab Emirates | 1 |
| Botswana | 1 |
Where are Research Centers of Biogen Patents Located?
10 Best Biogen Patents
US20030003097A1 is the most popular patent in the Biogen portfolio. It has received 510 citations so far from companies like Xencor Inc, Macrogenics Inc and Janssen Biotech Inc.
Below is the list of 10 most cited patents of Biogen:
| Publication Number | Citation Count |
| US20030003097A1 | 510 |
| US6455043B1 | 472 |
| WO2002079255A1 | 443 |
| US6399061B1 | 373 |
| US6682734B1 | 358 |
| US20050163782A1 | 332 |
| US20020009444A1 | 301 |
| US20070148164A1 | 288 |
| US6602503B1 | 263 |
| US20020006404A1 | 256 |
Which Companies are using Biogen Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Biogen patent portfolio are Immunomedics, Roche Holding and Amgen.
List of the top forward citing Companies –
| Company | Number of Patents |
| Immunomedics | 14 |
| Roche Holding Ag | 11 |
| Amgen | 10 |
| Genentech | 10 |
| Novartis | 8 |
| Chugai Seiyaku Kabushiki Kaisha | 7 |
| Bristol-Myers Squibb | 6 |
| Regeneron Pharmaceuticals Inc | 6 |
| Teva Pharmaceutical Industries | 6 |
| Xencor | 6 |
Count of 102 and 103 Type Rejections based on Biogen Patents
Top Biogen Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US20090252729A1 | 15 |
| US20070148164A1 | 14 |
| US20160259913A1 | 11 |
| US7422899B2 | 10 |
| US20090258420A1 | 9 |
| US20020193569A1 | 8 |
| US20050053598A1 | 8 |
| US7820161B1 | 7 |
| US20030157641A1 | 7 |
| US6896885B2 | 7 |
| US20050163782A1 | 7 |
| US7951918B2 | 7 |
| US20060182740A1 | 7 |
| US6455043B1 | 7 |
| US20060204503A1 | 6 |
What Percentage of Biogen US Patent Applications were Granted?
Biogen (Excluding its subsidiaries) has filed 70 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 52 have been granted leading to a grant rate of 78.7%.
Below are the key stats of Biogen patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Biogen?
| Law Firm | Total Applications | Success Rate |
| Pillsbury Winthrop Shaw Pittman Llp | 14 | 100.00% |
| Sidley Austin Llp | 11 | 90.91% |
| Arnold & Porter Kaye Scholer Llp | 10 | 50.00% |
| Pillsbury Winthrop Shaw Pittman Llp | 5 | 100.00% |
| Sterne Kessler Goldstein & Fox Pllc | 5 | 80.00% |
| Foley Hoag Llp W Bii & Bgh | 4 | 66.67% |
| Birch Stewart Kolasch & Birch Llp | 3 | 100.00% |
| Biogen | 2 | 100.00% |
| Genentech Inc | 2 | 50.00% |
| Lando & Anastasi Llp | 2 | 100.00% |
EXCLUSIVE INSIGHTS COMING SOON!